Antiasthmatic Effects of Hesperidin, a Potential Th2 Cytokine Antagonist, in a Mouse Model of Allergic Asthma

Background and Objective. The features of asthma are airway inflammation, reversible airflow obstruction, and an increased sensitivity to bronchoconstricting agents, termed airway hyperresponsiveness (AHR), excess production of Th2 cytokines, and eosinophil accumulation in the lungs. To investigate the antiasthmatic potential of hesperidin as well as the underlying mechanism involved, we studied the inhibitory effect and anti-inflammatory effect of hesperidin (HPN) on the production of Th2 cytokines, eotaxin, IL-17, -OVA-specific IgE in vivo asthma model mice. Methods. In this paper, BALB/c mice were systemically sensitized to ovalbumin (OVA) followed intratracheally, intraperitoneally, and by aerosol allergen challenges. We investigated the effect of HPN on airway hyperresponsiveness, pulmonary eosinophilic infiltration, various immune cell phenotypes, Th2 cytokine production and OVA-specific IgE production in a mouse model of asthma. Results. In BALB/c mice, we found that HPN-treated groups had suppressed eosinophil infiltration, allergic airway inflammation, and AHR, and these occurred by suppressing the production of IL-5, IL-17, and OVA-specific IgE. Conclusions. Our data suggest that the therapeutic mechanism by which HPN effectively treats asthma is based on reductions of Th2 cytokines (IL-5), eotaxin, OVA-specific IgE production, and eosinophil infiltration via inhibition of GATA-3 transcription factor.

[1]  P. Leder,et al.  Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Cieslewicz,et al.  The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. , 1999, The Journal of clinical investigation.

[3]  K. Chopra,et al.  Beneficial effect of hesperidin on lipopolysaccharide-induced hepatotoxicity. , 2006, Toxicology.

[4]  Tadashi Hase,et al.  Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. , 2008, Journal of nutritional science and vitaminology.

[5]  P. Leder,et al.  Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia , 1997, The Journal of experimental medicine.

[6]  M. Neurath,et al.  The role of Th1/Th2 polarization in mucosal immunity , 2002, Nature Medicine.

[7]  J-H Chung,et al.  Apoptotic effect of hesperidin through caspase3 activation in human colon cancer cells, SNU-C4. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  W. Paul,et al.  CD4 T cells: fates, functions, and faults. , 2008, Blood.

[9]  M. Cybulsky,et al.  Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. , 1996, The Journal of clinical investigation.

[10]  H. Nakajima,et al.  Role of IL-23 and Th17 Cells in Airway Inflammation in Asthma , 2010, Immune network.

[11]  D. Loegering,et al.  Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.

[12]  K. Ahn,et al.  Anti-inflammatory and anti-allergic effects of kefir in a mouse asthma model. , 2007, Immunobiology.

[13]  J. C. Pratt,et al.  A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness1 , 2001, The Journal of Immunology.

[14]  Hiroyuki Tanaka,et al.  The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma , 2001, Inflammation Research.

[15]  H. Junginger,et al.  Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. , 2007, International journal of pharmaceutics.

[16]  L. Glimcher,et al.  Lineage commitment in the immune system: the T helper lymphocyte grows up. , 2000, Genes & development.

[17]  J. Gamble,et al.  Recombinant human interleukin 5 is a selective activator of human eosinophil function , 1988, The Journal of experimental medicine.

[18]  J. Bousquet,et al.  Eosinophilic inflammation in asthma. , 1990, The New England journal of medicine.

[19]  P. Barnes.  Immunology of asthma and chronic obstructive pulmonary disease , 2008, Nature Reviews Immunology.

[20]  G. Ramakrishnan,et al.  Modulatory effect of hesperidin on benzo(a)pyrene induced experimental lung carcinogenesis with reference to COX-2, MMP-2 and MMP-9. , 2010, European journal of pharmacology.

[21]  M. Salvador,et al.  Antioxidant activity of the flavonoid hesperidin in chemical and biological systems. , 2005, Journal of agricultural and food chemistry.

[22]  J. Lötvall,et al.  Prolonged Eosinophil Production after Allergen Exposure in IFN‐γR KO Mice is IL‐5 Dependent , 2008, Scandinavian journal of immunology.

[23]  E. Ignatowicz,et al.  Citrus fruit flavonoids influence on neutrophil apoptosis and oxidative metabolism , 2008, Phytotherapy research : PTR.

[24]  Young-Hee Kang,et al.  Polyphenolic flavonoids differ in their antiapoptotic efficacy in hydrogen peroxide-treated human vascular endothelial cells. , 2003, The Journal of nutrition.

[25]  Sebastian P Fernandez,et al.  Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. , 2005, European journal of pharmacology.

[26]  C. Feng,et al.  A potential role for CD69 in thymocyte emigration. , 2002, International immunology.

[27]  A. Bossios,et al.  IL-17-producing T lymphocytes in lung tissue and in the bronchoalveolar space after exposure to endotoxin from Escherichia coli in vivo--effects of anti-inflammatory pharmacotherapy. , 2009, Pulmonary pharmacology & therapeutics.

[28]  Satoru Takahashi,et al.  Transcription factors T-bet and GATA-3 regulate development of airway remodeling. , 2006, American journal of respiratory and critical care medicine.

[29]  M. Hatano,et al.  IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. , 2008, American journal of respiratory and critical care medicine.

[30]  Q. Hamid,et al.  Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. , 2003, The Journal of allergy and clinical immunology.

[31]  Seung-Hyung Kim,et al.  Inhibitory effects of Actinidia polygama extract and cyclosporine A on OVA-induced eosinophilia and bronchial hyperresponsiveness in a murine model of asthma. , 2006, International immunopharmacology.

[32]  D. Ryan,et al.  The role of budesonide/formoterol for maintenance and relief in the management of asthma. , 2010, Pulmonary pharmacology & therapeutics.

[33]  C. Sanderson,et al.  Interleukin-5, eosinophils, and disease. , 1992, Blood.

[34]  A. Luster,et al.  T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila , 1996, The Journal of experimental medicine.

[35]  Yoshinobu Hirose,et al.  Inhibition of inducible isoforms of cyclooxygenase and nitric oxide synthase by flavonoid hesperidin in mouse macrophage cell line. , 2003, Cancer letters.

[36]  Kazuki Kanazawa,et al.  Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. , 2003, The Journal of nutrition.

[37]  J. R. Patil,et al.  Bioactive compounds from Mexican lime ( Citrus aurantifolia ) juice induce apoptosis in human pancreatic cells. , 2009, Journal of agricultural and food chemistry.

[38]  Seung-Hyung Kim,et al.  Effects of Radix Adenophorae and Cyclosporine A on an OVA-Induced Murine Model of Asthma by Suppressing to T Cells Activity, Eosinophilia, and Bronchial Hyperresponsiveness , 2008, Mediators of inflammation.

[39]  W. Ouyang,et al.  Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. , 1998, Immunity.

[40]  Takafumi Yoshikawa,et al.  A citrus flavonoid hesperidin suppresses infection-induced endotoxin shock in mice. , 2004, Biological & pharmaceutical bulletin.

[41]  D. Umetsu,et al.  TH1 and TH2 CD4+ cells in human allergic diseases. , 1997, The Journal of allergy and clinical immunology.

[42]  C. Combadière,et al.  Molecular Cloning of Human Eotaxin, an Eosinophil-selective CC Chemokine, and Identification of a Specific Eosinophil Eotaxin Receptor, CC Chemokine Receptor 3 (*) , 1996, The Journal of Biological Chemistry.

[43]  K. Austen,et al.  Innate cells and T helper 2 cell immunity in airway inflammation. , 2009, Immunity.

[44]  D. Wyss,et al.  Synergistic effect of formoterol and mometasone in a mouse model of allergic lung inflammation , 2007, British journal of pharmacology.

[45]  Xiquan Liang,et al.  Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. , 2002, Advances in experimental medicine and biology.

[46]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[47]  D D Donaldson,et al.  Interleukin-13: central mediator of allergic asthma , 1998 .

[48]  Y. Wan,et al.  Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3‐transfected cells , 2000, Journal of leukocyte biology.

[49]  Myung‐Sook Choi,et al.  Interactive effect of hesperidin and vitamin E supplements on cholesterol metabolism in high cholesterol-fed rats. , 2001, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[50]  R. Solari,et al.  An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils , 1997, The Journal of experimental medicine.